NCT01770223 A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113) Status WITHDRAWN Phase PHASE4
NCT01767701 Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01767688 A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031) Status COMPLETED Phase PHASE1
NCT01765127 An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest) Status COMPLETED Phase N/A
NCT01761266 A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT01760460 A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1) Status COMPLETED Phase PHASE3
NCT01760447 A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289) Status COMPLETED Phase PHASE3
NCT01758588 Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis Status TERMINATED Phase PHASE2
NCT01756079 A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105) Status COMPLETED Phase PHASE4
NCT01755156 A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024) Status COMPLETED Phase PHASE3
NCT01748643 CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity Status COMPLETED Phase PHASE4
NCT01748240 Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure Status TERMINATED Phase PHASE2
NCT01745068 Partnership for Applied Research in Fracture Prevention Programs for the Elderly Status UNKNOWN Phase NA
NCT01741012 Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients Status COMPLETED Phase PHASE1
NCT01739348 An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) Status TERMINATED Phase PHASE2/PHASE3
NCT01738646 Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients Status COMPLETED Phase PHASE2
NCT01737684 A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013) Status COMPLETED Phase PHASE1
NCT01737047 The Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty' Status COMPLETED Phase N/A
NCT01736917 Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT01736683 Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) Status COMPLETED Phase PHASE2